EURECON-VERLAG-GMBH
30.9.2021 18:07:05 CEST | Business Wire | Press release
The winner for the award "The Golden Tablet® " has been determined - BioNTech. In addition to the company's research activity, a large product pipeline with many innovations is decisive for the award, as well as the quality of the products. The ranking "Best Pharmaceutical Companies Germany 2021" was also published: Roche Pharma, Lilly, Bristol-Myers Squibb, Novartis Pharma and Amgen occupy places one to five in the Pharma Trend Image & Innovation Award survey.
Thirteen other winners were able to enjoy the award "Most Innovative Product". These include in the Rx category (prescription drugs): the COVID-19 vaccine Comirnaty® from BioNTech and Tolak® for the treatment of actinic keratoses from Pierre Fabre. Exeltis is awarded for both the oral contraceptive Slinda® and DeflaGyn® for the treatment of cervical dysplasia / erosions. In the Orphan Drugs category, Gilead Sciences' hepatitis D drug Hepcludex® , Kyowa Kirin's Poteligeo® for the treatment of mycosis fungoides and Sézary syndrome, and Incyte's Pemazyre® for the treatment of cholangiocarcinoma win.
In the Specialty Care segment, the prostate cancer drug Erleada® from Janssen-Cilag receives an award. The food supplement ImmunoBON® for allergy therapy by Bencard is the winner in the OTC category. The app MyIUS from Jenapharm, which accompanies users of intrauterine systems, was chosen in the Digital Health Applications category. Roche Diagnostics won in the Diagnostics category with the SARS-CoV-2 Rapid Antigen Test on the one hand, and the Avenio NGS Oncology Assay on the other. In the category Leap Innovations - Treatment of COVID-19, Formycon lands in first place followed by Ethris and Pieris Pharmaceuticals in second and third place.
The publication of the ranking and the presentation of the subject-specific awards took place on 14 September 2021 as a hybrid event in the Ehrensaal of the Deutsches Museum.
Further information on the ranking and the awards at https://pharma-trend.com/en/pharma-award/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210930005795/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corpay Cross-Border Named Official Foreign Exchange Provider of the ABB FIA Formula E World Championship10.3.2026 13:30:00 CET | Press release
Delivering exclusive commercial FX solutions to the world’s premier all-electric racing series Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, today announced that its Cross-Border business has partnered with Formula E, the world’s first all-electric FIA World Championship and B Corp Certified sport. Under the agreement, Corpay becomes the exclusive and Official Foreign Exchange Provider of the ABB FIA Formula E World Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310640540/en/ The ABB FIA Formula E World Championship brings dramatic racing to the heart of some of the world’s most iconic cities providing an elite motorsport platform for the world’s leading automotive manufacturers to accelerate electric vehicle innovation with the GEN3 Evo race continuing to set a new benchmark as the fastest-accelerating FIA single-seater, rocketing from 0-60 mph in an astonishing 1.82 seconds. Through th
Wolters Kluwer Releases 2026 Future Ready Lawyer Survey Report, Highlighting Rapid AI Gains and Shifting Power Dynamics10.3.2026 13:00:00 CET | Press release
Global survey of legal professionals reveals strong momentum behind AI investment and workflow transformation Wolters Kluwer Legal & Regulatory has published the results of its global 2026 Future Ready Lawyer Survey, the preeminent source of insights from lawyers in law firms and corporate legal departments across the U.S., China and nine European countries. The findings show an industry coming to grips with the accelerated adoption of AI technology, an ambitious undertaking that has yielded long sought-after efficiencies across workflows and business practices, while raising unexpected challenges to ethics and infrastructure. “The Future Ready Lawyer global report has always reflected an industry in motion,” said Martin O'Malley, CEO of Wolters Kluwer Legal & Regulatory. “What’s most striking this year is how rapidly legal professionals are accelerating to meet that change by reshaping business models, rethinking long‑held dynamics, and embracing new ways to deliver value through both
Armis Announces Armis Centrix™ for Vulnerability Management Detection and Response to Reduce Cyber Risk and Eliminate Operational Friction10.3.2026 13:00:00 CET | Press release
Solution empowers organizations to continuously and accurately detect vulnerabilities across the entire attack surface, while reducing scan volume and impact Armis, the cyber exposure management & security company, today announced Armis Centrix™ for Vulnerability Management Detection and Response. The solution enables security teams to precisely identify and validate vulnerabilities across all of an organization’s assets in real time. Armis’ unified approach to vulnerability assessment results in greater accuracy, faster detection time and reduced operational costs. "Waiting weeks for a vulnerability scan that still misses essential assets is no longer sufficient to combat AI-powered cyberattacks,” said Nadir Izrael, CTO and Co-Founder at Armis. “Organizations need a continuous view of their complete environment to stay ahead of threats. Armis' new solution delivers more accurate, targeted results than traditional vulnerability management solutions with a fraction of the scans. It empo
United UATP, Powered by TreviPay, Expands Corporate Travel Billing Program to New Global Markets10.3.2026 13:00:00 CET | Press release
Strategic market entry to Europe, Australia and New Zealand further strengthens United Airlines’ ability to serve agency and corporate customers with cost-free billing, flexible air travel payment options and enhanced reporting tools UATP, the global network that enables organizations to simplify payment processes and expand their payment capabilities, today announced the expansion of United Airlines’ cost-free UATP billing program (“United UATP”), powered by TreviPay, to Europe, Australia and New Zealand. This expansion opens new opportunities for corporate customers and travel agencies in these regions to access the benefits of United UATP, including cost-free, streamlined travel expense reconciliation. Since 2015, United UATP has collaborated with TreviPay, a fully managed B2B payments platform, to power its streamlined solution for air travel payments in the U.S. and Canada. For companies currently benefitting from the United UATP billing program, TreviPay handles customer service,
Nexpring Health Invests in May Health to Advance a Novel Technology to Treat PCOS-Related Infertility10.3.2026 13:00:00 CET | Press release
Strategic investment advances Nexpring Health's mission to move the fertility field forward, placing clinicians, embryologists, and fertility clinics at the center of every breakthrough, so they can focus on what matters most, their patients. Nexpring Health, a global leader in assisted reproductive technology (ART) solutions, today announced a strategic investment in May Health, a medical device company pioneering a novel treatment approach for women with polycystic ovary syndrome (PCOS)-related infertility. Nexpring Health joined May Health’s €10 million ($11.7M) financing round alongside investors including Sofinnova Partners, Trill Impact, and Bpifrance. This investment reflects Nexpring Health's commitment to driving meaningful innovation that moves the field of fertility care forward and goes beyond the products in the lab by supporting the innovations that redefine what’s possible for patients and the clinicians who serve them. Backing the Breakthrough That PCOS Patients Need PC
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom